Dentists in Cuba City, WI Accepting Medicare
4 Dentists found. Showing 1 - 4
 Benjamin Muhlstein, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 206 S Jackson St, Cuba City, WI 53807 Phone: 608-744-2111 |
Robert R Schroeder, DENTIST Dentist Medicare: Not Enrolled in Medicare Practice Location: 122 N Main St, Cuba City, WI 53807 Phone: 608-744-2111 Fax: 608-744-2112 |
Dr. Evan Pluym, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 206 S Jackson St, Cuba City, WI 53807 Phone: 608-744-2111 |
Matthew Paul Andrews, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 206 S Jackson St, Cuba City, WI 53807 Phone: 608-744-2111 Fax: 608-744-2112 |
News Archive
Low dose oral contraceptive effective in controlling premenstrual disorder
A new study led by researchers at Yale School of Medicine shows for the first time that a low dose oral contraceptive with a unique progestin and dosing regimen is effective in treating symptoms of premenstrual dysphoric disorder (PMDD), the most severe form of premenstrual syndrome.
Phase 2 study of PH20 with regular human insulin confirms faster insulin absorption
Halozyme Therapeutics, Inc. today announced additional Phase 2 results that demonstrated faster insulin absorption and increased peak insulin concentrations in type 1 diabetic patients after co-administration of its recombinant hyaluronidase enzyme (rHuPH20 or PH20) with Humulin® R (regular human insulin), a mealtime insulin.
Generic Coreg (carvedilol) approved in U.S.
The U.S. Food and Drug Administration has approved the first generic versions of Coreg (carvedilol). Coreg is a widely used medication that is FDA-approved to treat high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following a heart attack.
Researchers find gene variants that predict adverse effects of hyperthyroidism drugs
Researchers and doctors at Uppsala University, along with Swedish and international collaboration partners, have found gene variants that predict the risk of a serious adverse reaction to drugs used for the treatment of hyperthyroidism. The results are published in The Lancet Diabetes & Endocrinology.
New analytical approach can organize large amounts of varied cancer genetic data
The technology that allows scientists to profile the entire genome of individual tumors offers new hope for discovering ways to select the best treatment for each patient's particular type of cancer. However, these profiles produce huge amounts of data, and the volume alone creates unique analytical problems.
› Verified 6 days ago